1 | 8-cyclopentyl-1,3-dipropylxanthine | - | - |
- |
- |
215 2件: 215, 299 💬 |
2 | Artesunate | Artesunate 1件: Artesunate; | 1件: D02482 D02482 💬 |
- |
- |
046 7件: 46, 53, 66, 96, 97, 215, 271 💬 |
3 | Calcium | Amorphous calcium carbonate 34件: Amorphous calcium carbonate; Ascal(r) / carbasalate calcium; Atorvastatin calcium; Calcitriol & calcium; Calcium; Calcium and cholecalciferol; Calcium and vitamin d combination; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Calcium channel blockers; Calcium citrate; Calcium citrate with vitamin d2; Calcium gluconate; Calcium lactate; Calcium levofolinate; Calcium rosuvastatin; Calcium, dietary; Carbasalate calcium; Crestor tablets (calcium rosuvastatin) film-coated tablets; Crystalline calcium supplements; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Low molecular weight heparin calcium injection; Other: calcium stable isotope; Other: determination of calcium intake by a dietician interview; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Other: serum calcium concentrations results; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Vidofludimus calcium; Vidofludimus calcium dihydrate; | - |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
4 | Calcium gluconate | Calcium gluconate 1件: Calcium gluconate; | 1件: D00935 D00935 💬 |
- |
- |
214 3件: 214, 215, 235 💬 |
5 | Dexmedetomidine | Dexmedetomidine 10件: Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; | 2件: D00514 D00514
D01205 D01205 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
6 | Dobutamine | Dobutamine 2件: Dobutamine; Other: dobutamine; | 4件: D00632 D00632
D03879 D03879
D03880 D03880
D03881 D03881 💬 |
1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 3件: 57, 58, 215 💬 |
7 | Eplerenone | Eplerenone 1件: Eplerenone; | 1件: D01115 D01115 💬 |
1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
075 4件: 75, 113, 210, 215 💬 |
8 | Fentanyl | Fentanyl 8件: Fentanyl; Fentanyl (high dose); Fentanyl (low dose); Fentanyl (low dose) + dexmedetomidine; Fentanyl transdermal patch; Multi-modal pain management [fentanyl]; Standard analgesia use [fentanyl]; Transdermal fentanyl matrix, gabapentin; | 2件: D00320 D00320
D01399 D01399 💬 |
1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 4件: 46, 70, 215, 231 💬 |
9 | Flunarizine | - | 2件: D01303 D01303
D07971 D07971 💬 |
3件: CACNA1G, CACNA1H, CACNA1I 💬 |
Aldosterone synthesis and secretion 8件: Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus |
058 4件: 58, 86, 149, 215 💬 |
10 | Ketamine | Esketamine 6件: Esketamine; Esketamine hydrochloride; Ketamine; Multi-modal pain management [intravenous ketamine]; S-ketamine; S-ketamine & midazolam; | 2件: D00711 D00711
D08098 D08098 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 13, 70, 113, 156, 215 💬 |
11 | Losartan | Lisinopril, losartan, and atorvastatin 12件: Lisinopril, losartan, and atorvastatin; Losartan; Losartan and atenolol or propranolol; Losartan and nebivolol; Losartan and other angiotensin receptor blockers; Losartan bluefish 50 mg; Losartan hexal; Losartan potasico; Losartan potassium; Losartan tablets & qingremoshen granule; Other: losartan; Sildenafil and losartan; | 2件: D00357 D00357
D08146 D08146 💬 |
1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
12 | Phenoxymethylpenicillin | - | 3件: D00497 D00497
D02506 D02506
D05411 D05411 💬 |
- |
- |
013 3件: 13, 97, 215 💬 |
13 | Potassium | Dipotassium salt 5件: Dipotassium salt; Losartan potassium; Potassium; Potassium sparing diuretic; Potassium supplement; | 1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
14 | Sodium citrate | Sodium citrate 1件: Sodium citrate; | 2件: D01781 D01781
D05855 D05855 💬 |
- |
- |
067 4件: 67, 214, 215, 235 💬 |
15 | Tranexamic acid | Tranexamic acid 3件: Tranexamic acid; Tranexamic acid 100 mg/ml; Tranexamic acid injection [cyklokapron]; | 1件: D01136 D01136 💬 |
1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 5件: 46, 70, 215, 227, 288 💬 |
16 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |